These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27038699)

  • 1. CDODA-Me decreases specificity protein transcription factors and induces apoptosis in bladder cancer cells through induction of reactive oxygen species.
    Takeuchi H; Taoka R; Mmeje CO; Jinesh GG; Safe S; Kamat AM
    Urol Oncol; 2016 Aug; 34(8):337.e11-8. PubMed ID: 27038699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bladder cancer: CDODA-Me has anticancer activity.
    Fenner A
    Nat Rev Urol; 2016 May; 13(5):242. PubMed ID: 27091666
    [No Abstract]   [Full Text] [Related]  

  • 3. Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells.
    Chintharlapalli S; Papineni S; Abdelrahim M; Abudayyeh A; Jutooru I; Chadalapaka G; Wu F; Mertens-Talcott S; Vanderlaag K; Cho SD; Smith R; Safe S
    Int J Cancer; 2009 Oct; 125(8):1965-74. PubMed ID: 19582879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters.
    Kim K; Chadalapaka G; Pathi SS; Jin UH; Lee JS; Park YY; Cho SG; Chintharlapalli S; Safe S
    Mol Cancer Ther; 2012 Sep; 11(9):1852-62. PubMed ID: 22752225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyl 2-cyano-3,11-dioxo-18 beta-olean-1,12-dien-30-oate is a peroxisome proliferator-activated receptor-gamma agonist that induces receptor-independent apoptosis in LNCaP prostate cancer cells.
    Papineni S; Chintharlapalli S; Safe S
    Mol Pharmacol; 2008 Feb; 73(2):553-65. PubMed ID: 17989348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methyl 2-cyano-3,11-dioxo-18-olean-1,12-dien-30-oate (CDODA-Me), a derivative of glycyrrhetinic acid, functions as a potent angiogenesis inhibitor.
    Pang X; Zhang L; Wu Y; Lin L; Li J; Qu W; Safe S; Liu M
    J Pharmacol Exp Ther; 2010 Oct; 335(1):172-9. PubMed ID: 20631299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cells.
    Chintharlapalli S; Papineni S; Jutooru I; McAlees A; Safe S
    Mol Cancer Ther; 2007 May; 6(5):1588-98. PubMed ID: 17513608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of pituitary tumor-transforming gene-1 in thyroid cancer cells by drugs that decrease specificity proteins.
    Chintharlapalli S; Papineni S; Lee SO; Lei P; Jin UH; Sherman SI; Santarpia L; Safe S
    Mol Carcinog; 2011 Sep; 50(9):655-67. PubMed ID: 21268135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactive Oxygen Species (ROS)-Inducing Triterpenoid Inhibits Rhabdomyosarcoma Cell and Tumor Growth through Targeting Sp Transcription Factors.
    Kasiappan R; Jutooru I; Mohankumar K; Karki K; Lacey A; Safe S
    Mol Cancer Res; 2019 Mar; 17(3):794-805. PubMed ID: 30610105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growth.
    Jutooru I; Chadalapaka G; Sreevalsan S; Lei P; Barhoumi R; Burghardt R; Safe S
    Exp Cell Res; 2010 Aug; 316(13):2174-88. PubMed ID: 20435036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis and nonsteroidal anti-inflammatory drug-activated gene 1 in pancreatic cancer cells by a glycyrrhetinic acid derivative.
    Jutooru I; Chadalapaka G; Chintharlapalli S; Papineni S; Safe S
    Mol Carcinog; 2009 Aug; 48(8):692-702. PubMed ID: 19125423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a.
    Jutooru I; Chadalapaka G; Abdelrahim M; Basha MR; Samudio I; Konopleva M; Andreeff M; Safe S
    Mol Pharmacol; 2010 Aug; 78(2):226-36. PubMed ID: 20488920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emodin enhances cisplatin-induced cytotoxicity in human bladder cancer cells through ROS elevation and MRP1 downregulation.
    Li X; Wang H; Wang J; Chen Y; Yin X; Shi G; Li H; Hu Z; Liang X
    BMC Cancer; 2016 Aug; 16():578. PubMed ID: 27485374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nortriptyline induces mitochondria and death receptor-mediated apoptosis in bladder cancer cells and inhibits bladder tumor growth in vivo.
    Yuan SY; Cheng CL; Ho HC; Wang SS; Chiu KY; Su CK; Ou YC; Lin CC
    Eur J Pharmacol; 2015 Aug; 761():309-20. PubMed ID: 26086857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs.
    Gandhy SU; Kim K; Larsen L; Rosengren RJ; Safe S
    BMC Cancer; 2012 Nov; 12():564. PubMed ID: 23194063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzyl Isothiocyanate (BITC) Induces Reactive Oxygen Species-dependent Repression of STAT3 Protein by Down-regulation of Specificity Proteins in Pancreatic Cancer.
    Kasiappan R; Jutooru I; Karki K; Hedrick E; Safe S
    J Biol Chem; 2016 Dec; 291(53):27122-27133. PubMed ID: 27875298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celastrol decreases specificity proteins (Sp) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cells.
    Chadalapaka G; Jutooru I; Safe S
    Carcinogenesis; 2012 Apr; 33(4):886-94. PubMed ID: 22334592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors.
    Chintharlapalli S; Papineni S; Lei P; Pathi S; Safe S
    BMC Cancer; 2011 Aug; 11():371. PubMed ID: 21864401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 18β-glycyrrhetinic acid conjugate with Vorinostat degrades HDAC3 and HDAC6 with improved antitumor effects.
    Huang M; Xie X; Gong P; Wei Y; Du H; Xu Y; Xu Q; Jing Y; Zhao L
    Eur J Med Chem; 2020 Feb; 188():111991. PubMed ID: 31883490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baicalein induces apoptosis via ROS-dependent activation of caspases in human bladder cancer 5637 cells.
    Choi EO; Park C; Hwang HJ; Hong SH; Kim GY; Cho EJ; Kim WJ; Choi YH
    Int J Oncol; 2016 Sep; 49(3):1009-18. PubMed ID: 27571890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.